Leilei Jiang

机构：Peking University, Peking University Cancer Hospital, Ministry of Education · ORCID：0000-0002-9610-6525

发表论文 31 篇 · 总被引 177 次 · h-index 8

代表论文

• High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial (2024 · The Lancet Respiratory Medicine · 被引 43)
• First-line atezolizumab/durvalumab plus platinum–etoposide combined with radiotherapy in extensive-stage small-cell lung cancer (2023 · BMC Cancer · 被引 32)
• Induction immunochemotherapy followed by radiotherapy for patients with unresectable locally advanced or metastatic esophageal cancer: A propensity score-matched analysis (2023 · International Immunopharmacology · 被引 17)
• Prediction of Clinical Outcome in Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy by Plasma Markers (2021 · Frontiers in Oncology · 被引 13)
• Hypofractionated Volumetric-Modulated Arc Radiotherapy for Patients With Non-Small-Cell Lung Cancer Not Suitable for Surgery or Conventional Chemoradiotherapy or SBRT (2021 · Frontiers in Oncology · 被引 10)
• Atrial fibrillation in cancer patients: Epidemiology, identification and management (2025 · Seminars in Cancer Biology · 被引 7)